WO2026103858 - RXFP1 RECEPTOR AGONIST ANALOG, PREPARATION METHOD THEREFOR, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/103858
Publication Date
21.05.2026
International Application No.
PCT/CN2025/134984
International Filing Date
14.11.2025
Title **
[English]
RXFP1 RECEPTOR AGONIST ANALOG, PREPARATION METHOD THEREFOR, AND USE THEREOF
[French]
ANALOGUE D'AGONISTE DU RÉCEPTEUR RXFP1, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
一种RXFP1受体激动剂类似物及其制备方法和用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
LU, Yinsuo
JIA, Shuanglong
WANG, Zongtao
ZOU, Junlong
BAI, Yang
Priority Data
202411643283.1
15.11.2024
CN
202411808492.7
09.12.2024
CN
202510297618.7
13.03.2025
CN
202510307897.0
13.03.2025
CN
202511657391.9
12.11.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2016 | |
| EPO | Filing, Examination, Granting | 11827 | |
| Japan | Filing, Examination, Granting | 2153 | |
| South Korea | Filing, Examination, Granting | 2268 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,004
Contact Us
Abstract[English]
The present invention relates to the technical field of chemical drugs, and provides an RXFP1 receptor agonist analog, a preparation method therefor, and a use thereof. A compound provided by the present invention exhibits good RXFP1 receptor agonist activity and can be used for treating heart failure.[French]
La présente invention relève du domaine technique des médicaments chimiques, et concerne un analogue d'agoniste du récepteur RXFP1, son procédé de préparation et son utilisation. Un composé selon la présente invention présente une bonne activité agoniste du récepteur RXFP1 et peut être utilisé pour traiter une insuffisance cardiaque.[Chinese]
本发明属于化学药物技术领域，提供了一种RXFP1受体激动剂类似物及其制备方法和用途，本发明提供的化合物具有很好的RXFP1受体激动活性，可用于治疗心力衰竭。